Zealand Pharma Announces That Its Partner Sanofi Has Applied for Regulatory … – MarketWatch (press release)
See on Scoop.it – Diabetes Counselling
Zealand Pharma Announces That Its Partner Sanofi Has Applied for Regulatory …MarketWatch (press release)Lixisenatide is a once-daily investigational GLP-1 agonist, invented by Zealand Pharma and licensed to Sanofi for the treatment of Type 2…
See on www.marketwatch.com